The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson’s disease

Background: NICE in England, and ICER in the US both use cost-utility analyses (CUA) and budget impact analyses (BIA) to assess value for money and affordability, however the thresholds used differ greatly. Objective: To perform a cross-country comparison of the results of the CUA and BIA and detail...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørgensen, Jesper, Servos, Spiros, Kefalas, Panos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198614/
https://www.ncbi.nlm.nih.gov/pubmed/30364868
http://dx.doi.org/10.1080/20016689.2018.1500419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198614/
https://www.ncbi.nlm.nih.gov/pubmed/30364868
http://dx.doi.org/10.1080/20016689.2018.1500419

Ejemplares similares